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Background: Structural brain abnormalities are consistently found in schizophrenia (Sz) and have been associatedwith the familial risk for
the disorder. We aim to define the relative contributions of genetic and nongenetic factors to the association between structural brain
abnormalities and Sz in a uniquely powered cohort (Schizophrenia Twins and Relatives consortium).
Methods: An international multicenter magnetic resonance imaging collaboration was set up to pool magnetic resonance imaging scans
from twin pairs in Utrecht (The Netherlands), Helsinki (Finland), London (United Kingdom), and Jena (Germany). A sample of 684 subjects
tookpart, consistingofmonozygotic twins (n410,with51patients fromconcordant and52 fromdiscordantpairs) anddizygotic twins (n
74, with 39 patients from discordant pairs). The additive genetic, common, and unique environmental contributions to the association
etween brain volumes and risk for Sz were estimated by structural equation modeling.
esults: The heritabilities of most brain volumes were significant and ranged between 52% (temporal cortical gray matter) and 76%
cerebrum). Heritability of cerebral graymatter did not reach significance (34%). Significant phenotypic correlationswere foundbetween Sz
nd reduced volumes of the cerebrum (.22 [.30/.14]) andwhitematter (.17 [.25/.09]) and increased volume of the third ventricle
.18 [.08/.28]). These were predominantly due to overlapping genetic effects (77%, 94%, and 83%, respectively).onclusions: Some of the genes that transmit the risk for Sz also influence cerebral (white matter) volume.
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A lthough the causes of schizophrenia (Sz) are not completelyunderstood, the importance of genetic factors has beenfirmly established by family, twin, and adoption studies.
here is evidence for a substantial genetic contribution to the eti-
logy of Sz, with heritability estimates up to 85% (1,2). Over the last
ecade a large number of linkage and (genome-wide) association
tudies have been carried out (3–5). The genes thus far identified
From the University Medical Center Utrecht (NEMvH, HGS, HEHP, RSK), De-
partment of Psychiatry, Division of Neuroscience, Rudolf Magnus Insti-
tute, Utrecht; VU University Amsterdam (DIB), Netherlands Twin Regis-
ter, Department of Biological Psychology, Amsterdam, TheNetherlands;
Institute of Psychiatry (FR, MMP, TT, RMM), Kings College London, Lon-
don; St. Andrew’s Academic Centre (MMP), King’s College London, Insti-
tute of Psychiatry, Northampton, United Kingdom; Department of
General Adult Psychiatry (MW), Centre for Psychosocial Medicine,
Heidelberg, and SRH Klinikum, Karlsbad-Langensteinbach; University of
Jena (HS), Department of Psychiatry, Germany; Department of Psychia-
try and Human Behavior (TGvE), University of California Irvine, Irvine;
Departments of Psychology and Psychiatry and Biobehavioral Sciences
(TDC),University ofCalifornia at LosAngeles, LosAngeles, California; and
theDepartment ofMental Health andAlcohol Research (MOH), National
Health Institute, Helsinki, Finland.
Authors NEMvH and FR contributed equally to this work.
Address correspondence to Neeltje E.M. van Haren, Ph.D., Rudolf Magnus
Institute of Neuroscience, Department of Psychiatry, University Medical
Center Utrecht, Heidelberglaan 100, A. 01.126, Utrecht 3584 CX, The
Netherlands; E-mail: n.e.m.vanharen@umcutrecht.nl.tReceived Aug 25, 2011; revised Dec 16, 2011; accepted Jan 3, 2012.
0006-3223/$36.00
doi:10.1016/j.biopsych.2012.01.010nly explain a small part of the genetic risk for Sz, although many
eem to be involved in neurodevelopmental processes (6–8). This
uggests that some of the genetic risk leading to the development
f Sz is expressed as abnormal brain development.
In fact, abnormal brain structure is one of the most robust bio-
ogical features of Sz (9). Volume loss in the prefrontal lobes, thala-
us, superior temporal cortex, andhippocampushave consistently
een demonstrated with in vivo and postmortem approaches (10).
t is well-known that brain volume (BV) is highly heritable (11,12)
nd that the brain abnormalities found in Sz cosegregate with the
llness within families (13,14). Furthermore, twin probands have
maller whole BVs than their nonaffected co-twins, who in turn
ave smaller brains than healthy twins (15–17). Hulshoff Pol et al.
18) showed that smaller white matter volume reflects the expres-
ion of genetic risk, whereas less gray matter is related to environ-
ental risk factors. Thus, family and twin studies to date suggest
hat some of the brain abnormalities in Sz can be attributed to the
enes conferring risk for this disorder. Although several twin-stud-
es have tried to quantify the relative contribution of genetic and
ongenetic factors to these brain abnormalities, these studies have
ll been small (due to recruitment challenges) and lacked power,
eading to unreliable estimates. Furthermore, for a phenotype or
ndophenotype to be useful in the search for disease-related
enes, it should not only be heritable but also share genetic vari-
nce with the risk for the disorder. Few studies have tested for such
leiotropic effects. The STAR (Schizophrenia Twins and Relatives)
onsortiumwas established to address thesemethodological prob-
ems, combiningbrain imagingdata frommostof theavailable twin
amples with Sz.
Although the need to pool twin samples to gain sufficient statis-
ical power is not disputed, it is a great challenge to combine struc-
BIOL PSYCHIATRY 2012;71:915–921
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916 BIOL PSYCHIATRY 2012;71:915–921 N.E.M. van Haren et al.tural magnetic resonance imaging (MRI) data, given the variability
of magnetic resonance scanners and acquisition protocols be-
tween sites. The ADNI (Alzheimer’s Disease Neuroimaging Initia-
tive) (19) andBIRN (Biomedical Informatics ResearchNetwork) stud-
ies (20,21) developed useful recommendations on how best to
conduct multicenter imaging protocols; however, in the present
multicenter study, tuning of the MRI acquisition protocols was not
possible because scans of the twin pairs were already acquired.
Therefore, a group of calibration subjects was scanned at all partic-
ipating research sites,with the sameacquisitionprotocols the twins
were scanned with. The image processing pipeline algorithm was
optimized by tuning two calibration factors that separated gray
matter, white matter, and cerebrospinal fluid. This resulted in com-
parable between-site volumes for whole brain, cerebral gray and
white matter volume, cerebellum, and third and lateral ventricles
across most sites (22) (see also Methods and Materials). Conse-
quently, we are confident that using the calibration factors from
this study in the processing of the MRI twin data resulted in a
reliable and unique powered sample. We investigated the relative
contribution of genetic and environmental influences on the asso-
ciation between Sz liability and BV.
Methods andMaterials
Subjects
The STAR consortium pooled all twin samples with MRI brain
scans, collected at the Institute of Psychiatry, London (United King-
dom), University of Helsinki, Helsinki (Finland, in collaboration with
University of California, Los Angeles), University of Jena, Jena (Ger-
many), Universitätskliniek Heidelberg, Heidelberg (Germany), and
the University Medical Center Utrecht, Utrecht (UMCU, The Nether-
lands), to increase power for variance component analyses. All
availableMRI scans were collatedwithin the Department of Psychi-
atry at the UMCU and processed with our processing pipeline (see
following). Previously a calibration and data compatibility study
concluded that the Heidelberg scans could not be reliably pooled
with the other sites, due to low interscanner reliability (intraclass
coefficients) of the gray and white matter volumes (22).
High-quality MRI scans were available for 684 individuals, in-
cluding 142 patients with Sz and 542 unaffected individuals (co-
twins and control twins). Mean age in the total sample was 37.97
years (SD 11.31). Table 1 lists the numbers of included individuals
as a function of disease state, site, age, and gender.
Information on recruitment and psychiatric assessment for each
site is described in Supplement 1.
MRI Processing
Scans were acquired on Philips (Utrecht, The Netherlands; Jena,
Germany), GE (London, United Kingdom), and Siemens (Munich,
Table 1. Number of Twins, Mean Age, and Gender Distribution of the Samp
Helsinki Jena
n Age (yrs)
Gender
(F/M) n Age (yrs)
G
MZ-Conc 13 42.31 (8.44) 6/7
MZ-Disc Pt 14 47.93 (3.63) 8/6 11 34.46 (11.07)
Co-Twin 15 48.20 (5.36) 9/6 11 34.45 (11.07)
MZ-HC 48 47.77 (3.48) 22/26 16 34.98 (12.62)
DZ-Disc Pt 23 47.43 (5.03) 11/12
Co-Twin 23 48.30 (5.57) 12/11
DZ-HC 50 49.32 (4.68) 29/21N 684. Age given in years (SD).
Conc, concordant; Disc, discordant; DZ, dizygotic; F, female; HC, healthy contr
www.sobp.org/journalermany) systems. Differences in scan acquisition between sites
oncerned, amongothers, scan orientation (coronal or sagittal) and
oxel dimensions (see Table S1 in Supplement 1). The London twins
ere scanned at St. Georges Hospital (n 78) and at the Maudsley
ospital (n 54) on identical 1.5-T GE Signa scanners with slightly
ifferent acquisition protocols (16). Six twinswere scanned onboth
canners. Intraclass correlation coefficient (ICC) estimates ranged
rom .84 (cerebral gray matter) to .95 (lateral ventricles).
Image processing of the brain scans from Utrecht, London, and
ena was done on the neuroimaging computer network of the
epartment of Psychiatry in Utrecht. The reproducibility of the
egmentation process on scans from the Utrecht scanner was es-
ablished with ICC (23) and were .96 or higher for all structures
24–26). The T1-weighted images were first put into Talairach ori-
ntation (no scaling) (27). If a T2-weighted image was available
Utrecht and London), an intracranial volume was automatically
egmented from this image. After registration to the T1-weighted
mage with a mutual informationmaximization algorithm (28), this
egment served as a mask for further segmentation steps. If no
2-weighted image was available, an intracranial mask was manu-
lly segmented from the T1-weighted image.
The T1-weighted images were corrected for scanner radiofre-
uency-field nonuniformity (29). Total brain segmentations were
oneautomatically,withmathematicalmorphologyoperations, on
hebasis of thresholds obtained from the steepest slope of the gray
atter peak in intensity histograms of the intracranial region (i.e.,
he cerebrospinal fluid/gray matter separation threshold is the po-
ition of the steepest slopemultiplied by a calibrated factor [.73 for
cans from all sites]). This has been validated before (22,25).
Cerebellum and lateral and third ventricular segmentations
ere carried out semi-automatically on the basis of histogramanal-
ses followed by mathematical morphology operations on the T1-
eighted image. Anatomic knowledge-based selection principles
ere used for these segmentations. All segments were checked
nd manually corrected if necessary.
Separation of cerebral gray and white matter was done by ap-
lying a single threshold to the voxels of the total brain in the
1-weighted image. For each image, the threshold was obtained
utomatically from the T1-weighted intensity histogram (25). We
ave previously shown (25) that a scaling factor has to be cali-
rated, because of the dependence of the shapes of the gray and
hite matter distributions on the acquisition parameters. It was
alculated for Utrecht scans on the basis of a comparison in 80
cans,where thegray/white separationhadbeendeterminedman-
ally twice by three raters (fgw .960). For scans from London and
ena, the threshold factors for gray/white separation were opti-
ized (22) (London: fgw .980; Jena: fgw .970).
ite
London Utrecht
r
n Age (yrs)
Gender
(F/M) n Age (yrs)
Gender
(F/M)
38 35.26 (9.13) 9/29
14 30.71 (10.86) 4/10 13 37.52 (11.18) 6/7
17 32.51 (12.92) 7/10 13 37.55 (11.15) 6/7
53 36.43 (10.13) 20/33 134 33.99 (10.93) 66/68
3 43.88 (17.24) 2/1 13 35.38 (11.04) 6/7
3 43.88 (17.24) 2/1 13 35.23 (10.58) 6/7
4 37.00 (13.86) 0/4 142 32.66 (10.35) 81/61les/S
ende
(F/M)
6/5
6/5
8/8ol subjects; M, male; MZ, monozygotic; Pt, patient.
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N.E.M. van Haren et al. BIOL PSYCHIATRY 2012;71:915–921 917To obtain the cerebral whitematter segmentation of the image,
a selection of all voxels in the cerebrum with intensities above the
calibrated threshold was made. The gray matter segment was cal-
culated from the difference between the cerebrum segment and
cerebral white matter segment. Absolute volumes were estimated
from the product of the number of voxels in each segment and the
voxel volume.
In addition, frontal, parietal, temporal, and occipital lobes were
manually demarcated on a model brain (30) that was selected ear-
lier among200brain images of subjects between16 and70 years of
age (31). Brain images were registered to the model brain through
the Automatic Non-linear Image Matching and Anatomical Label-
ing (ANIMAL) algorithm (32) to remove global differences in size
and shape of the individual brains. The inverse of the transforma-
tion process registered the manual segmentations of the model
brain to the brain images of all subjects. The gray matter segments
from the individual brain images were used to identify cortical gray
matter for each individual lobe.
The Helsinki images were processed with a processing pipeline
at the University of California at Los Angeles. In brief, a semi-auto-
matedmethod based onMontreal Neurological Institute tools was
used to create brain-only masks, and trained operators subse-
quently outlined the brain parenchyma on each section, eliminat-
ing pixels corresponding to the skull and meninges. A radiofre-
quency bias field correction algorithm eliminated intensity drifts due
to scanner field inhomogeneity (29). The FunctionalMRI of the Brain’s
Automated Segmentation Tool (FAST) (33) was used to classify tissue
types into graymatter, whitematter, and cerebrospinal fluid.
Because a calibration dataset was available from four subjects
scanned in Helsinki and Utrecht (i.e., eight scans in total), we were
able toestimate the reliability ofpoolingdata fromthe twoprocess-
ing procedures. All eight scans were processed with both proce-
dures, and ICCsweremeasured for cerebral (gray andwhitematter)
volumes. These were all .99 after including site as a covariate.
Therefore, cerebral (gray and white matter) volumes from the Hel-
sinki twin sample were included in the analysis.
Statistical Analysis
Polychoric Correlations. To analyze the Sz data, a liability
threshold model was applied, which assumes that disease risk is
distributed normally (with a variance of one andmean of zero) (34).
A threshold separates the distribution into affected and unaffected
Table 2. Polychoric Correlations Within-Member Cross-Trait, Cross-Membe
BVs
Within-Member Cross-Trait
(Szm1– BVm1 Szm2 – BVm2)
Whole Sample
Cross-
MZ Pair
Cerebrum .22 (.30 to .14)a .77 (.69 to
erebral Gray .08 (.11 to .00) .57 (.45 to
Cerebral White .17 (.25 to .09)a .73 (.65 to
Lateral Ventricles .10 (.00 to .10) .73 (.63 to
rd Ventricle .19 (.09 to .29)a .75 (.67 to
Frontal Cortical Gray .03 (.13 to .06) .56 (.43 to
emporal Cortical Gray .04 (.14 to .06) .56 (.42 to
arietal Cortical Gray .03 (.07 to .13) .68 (.56 to
ccipital Cortical Gray .02 (.09 to .02) .65 (.53 to
Values given are n (95% confidence interval), estimated from the combin
(Szm1-Szm2) is constrained to be .92 in MZ pairs and .515 in DZ pairs; the thre
re constrained such that Szm1-BVm1 Szm2-BVm2, and the cross-member c
BV, brain volume; MRI, magnetic resonance imaging; subscript m, memb
aConfidence intervals not including zero indicate significance.individuals. The liability distribution is unobserved, and its variance (an be attributed to genetic and nongenetic factors. Resemblance
etween twins on the liability distribution is summarized with tet-
achoric (dichotomous traits) or polychoric correlations (traits with
1 threshold). The twin data were analyzed as a function of zygos-
ty (monozygotic [MZ] and dizygotic [DZ]) with Sz status (yes/no)
nd BVs as outcome variables. Brain volumeswere categorized into
ve classes (with roughly equal numbers/class) after regressing out
heeffects of one site (i.e., Helsinki, becauseof thedifferentprocess-
ng procedure), gender, age, and intracranial volume.
Polychoric (twin) correlations between the underlying liabilities
or Sz and BV were estimated as a function of zygosity. The correla-
ions estimated are: cross-trait within-member (Szm1–BVm1), with-
n-trait cross-members in pairs of MZ twins or DZ twins (Szm1–Szm2
r BVm1–BVm2), cross-trait cross-member in pairs of MZ twins or DZ
wins (Szm1–BVm2 or BVm1–Szm2). Several constraints were im-
osed. The cross-trait within-member correlations were con-
trained to be equal across all individuals in the sample, yielding
nly one Sz–BV correlation. The cross-trait cross-member correla-
ions were constrained to be equal within theMZ twin and DZ twin
roup separately, such that Szm1–BVm2 Szm2–BVm1 (Table 2). The
hresholds for BVs were constrained to be equal across groups.
Interpretation of Correlations. Significant cross-trait within-
ember correlations might imply common etiological influences.
he power to distinguish between different factors (e.g., genetic or
nvironmental) causing the correlation is derived from the MZ and
Z cross-trait cross-member correlations of the MZ twin pairs and
Z twin pairs. Significant cross-trait cross-member correlations
e.g., Szm1–BVm2) imply that these common etiological influences
re familial. Whether these familial influences are genetic or envi-
onmental in origin is indicated by the MZ/DZ ratio of these corre-
ations. A 2:1 ratio is indicative of additive genetic effects, whereas a
:1 ratio suggests the influences of (shared) common environment
n inducing a correlation between the traits. Nonsignificant cross-
rait cross-member correlations imply that the etiological influ-
ncesonSz andBVaredue to specificuniqueenvironmental effects
for background information see Neale et al. [35]).
GeneticModel Fitting. The aim of this study is to examine the
xtent of the correlationbetweenSz andBVsdue togenetic overlap
r to common environmental effects. Mx Statistical Modeling (36)
as used for maximum likelihood genetic model fitting to directly
stimate model parameters from the observed data. The genetic
ivariate model is illustrated in Figure 1A. Additive genetic effects
in-Trait, and Cross-Member Cross-Trait for Sz and MRI BVs
er Within-Trait
1 – BVm2)
Cross-Member Cross-Trait
(Szm1 – BVm2 Szm2 – BVm1)
DZ Pairs MZ Pairs DZ Pairs
.25 (.04 to .44)a .17 (.25 to .09)a .09 (.22 to .04)
.40 (.20 to .56)a .02 (.10 to .07) .07 (.06 to .20)
.41 (.23 to .55)a .16 (.24 to .07)a .14 (.26 to .01)a
.37 (.13 to .56)a .04 (.07 to .14) .00 (.19 to .17)
.40 (.16 to .59)a .16 (.05 to .26)a .18 (.00 to .35)
.34 (.10 to .54)a .07 (.03 to .17) .07 (.12 to .25)
.23 (.01 to .43) .02 (.03 to .12) .11 (.09 to .29)
.32a(.10 to .51) .07 (.03 to .17) .05 (.13 to .23)
.52 (.31 to .67)a .03 (.08 to .07) .20 (.02 to .36)a
mple of MZ and DZ twins. The cross-member within-trait correlation for Sz
fixed to give a 1% prevalence. The within-member cross-trait correlations
rait correlations are constrained such that Szm1-BVm2 Szm2-BVm1.
a pair; other abbreviations as in Table 1.r With
Memb
(BVm
s
.82)a
.66)a
.80)a
.80)a
.82)a
.67)a
.67)a
.76)a
.74)a
ed sa
shold
ross-tA), common environmental (C) and unique environmental ef-
www.sobp.org/journal
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918 BIOL PSYCHIATRY 2012;71:915–921 N.E.M. van Haren et al.fects—including measurement error (E)—are specified such that
factors A1, C1, and E1 influence both Sz (path ac, cc, ec) and BV (path
a‘c, c‘c, e‘c), inducing a familial covariance that is either genetic (ac*
a’c) or environmental (cc * c’c) and an individual specific environ-
ental covariance (ec * e’c). Factors A2, C2, and E2 are specific to BV
(as, cs, es). If there is no relevance in the specific order of the vari-
bles, the solutionof this Choleskydecomposition canbe standard-
zed in a correlated-factors model (Figure 1B), where for example
he paths from A1 to Sz and A2 to BV are the square roots of their
heritabilities, andwhere the correlational pathbetweenA1andA2 is
he genetic correlation (rg). The part of the phenotypic correlation
rph), due to genetic effects can then be calculated by ( h
2
SZ * rg *
 h2BV), the part due to C by ( c
2
SZ * rc * c
2
BV) and the part due
to E by ( e2SZ * re * e
2
BV).
Ascertainment Correction. The data are from twin pairs se-
ected on the basis of the presence or absence of Sz rather than
rom a randompopulation sample, requiring a correction for ascer-
ainment. We corrected for ascertainment by constraining the ge-
etic model parameters for Sz to constant values: point estimates
h2 .81, c2 .11, e2 .08) froma recentmeta-analysis (37) and the
liability threshold togive aprevalence consistentwith a lifetime risk
of 1%. In contrast, themodel parameters for brain structure (includ-
ing liability thresholds) as well as the relationship with Sz are free
parameters tobeestimated from thedata (Figure 1). This correction
in thepolychoric correlation scripts entails fixing theMZandDZ/sib
correlations for Sz to h2c2 .92 and to .5h2 c2 .515, respec-
tively. This model has been described elsewhere inmore detail (17)
and applied to other Sz studies (38–40).
Results
Polychoric Correlations
Correlations between the underlying liabilities for Sz and each
Figure 1. (A) The applied bivariatemodel. Additive genetic effects: A; comm
actors A1, C1, and E1 influenceboth schizophrenia (Sz; path ac, cc, ec) andbra
(ac* a’c) or environmental (cc * c’c) and an individual specific environmenta
tandardized correlated-factors solution, where the paths are the square
the genetic c and e correlations (rg, rc, re). The proportion of the phenotypic
hepart due toCeffectsby ( c2SZ * rc * c
2
BV), and thepart due toEeffectsb
or schizophrenia are: h2 .81, c2 .11, e2 .08.BV are presented in Table 2. First, the ratios of the MZ and DZ twin d
www.sobp.org/journalorrelation indicate a significant contribution of genetic effects to
he observed variation for each of the BVs (Figure 2). Second, signif-
cant cross-trait within-member correlations (column 1) were pres-
nt for: 1) reduced cerebral and cerebral white matter volume, and
) increased third ventricle volume. The significant MZ and DZ
ross-member cross-trait correlations for each volumedo support a
enetically mediated association with risk for Sz. This is formally
ested in the genetic model-fitting analyses.
enetic Model Fitting
The results from the ACEmodel-fitting are presented in Table 3.
ost of the BVs measured were significantly heritable and ranged
etween 52% (temporal cortical gray matter) and 76% (total cere-
ral volume). Heritability of cerebral gray matter (in particular, cor-
ical frontal and occipital: 43% and 21%, respectively) did not reach
ignificance (34%). Familial (common) environmental influences
c2) on the variation in each of the volumes were nonsignificant,
xcept for cortical occipital gray matter volume (43%). The genetic
rg), shared-environmental (rc) and unique-environmental correla-
ions (re) indicate that the source of the significant phenotypic
verlap between risk for Sz and cerebral volume decrease was due
o genetic and unique-environmental factors (including correlated
easurement error). For graymatter (in particular, frontal and tem-
oral cortex) volume and lateral ventricle volume, these were all
ue to nonfamilial factors (i.e., correlated unique-environmental
actors).
Table S2 in Supplement 1 shows the more parsimonious AE
odels, where all nonsignificant common-environmental effects
re ignored. There was a significant genetic correlation between
educed cerebral volumeand risk for Sz (rg.21, 95%confidence
nterval [CI]: .31 to .10). The phenotypic correlation between
educed cerebral volume and Sz risk of.22 (r ) could be broken
vironmental: C; and unique environmental effects: E are specified such that
me (BV; path a’c, c’c, e’c), inducing a familial covariance that is either genetic
riance (ec * e’c). Factors A2, C2, and E2 are specific to BV (as, cs, es). (B) The
s of the heritabilities (h2), c2, and e2 and the double-headed arrows are
ation (rph) due to A effects can then be calculated by ( h
2
SZ * rg * h
2
BV),
e2SZ * re * e
2
BV). For ascertainment correction, thefixedmodelparameterson en
in volu
l cova
root
correl
y (ph
own,with77%due to commongenetic factors (rph-a.17, 95%
rc
c
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N.E.M. van Haren et al. BIOL PSYCHIATRY 2012;71:915–921 919CI:.25 to.08), and 23% due to correlated subject-specific envi-
onmental factors (rph-e.05, 95% CI:.08 to.02).
Furthermore, for both reduced cerebral white matter and in-
reased third ventricle volume, there was a significant phenotypic
orrelation with risk for Sz (rph.17, 95% CI:.25 to.09; rph
18, 95% CI: .08 to .28, respectively). Genetic influences contribute
ignificantly to the association between both structures and Sz
iability. For cerebral white matter volume, overlapping A (genetic)
actors.15 (95%CI:.24 to.07) accounting for approximately
4%. For increased third ventricle volume the part due to overlap-
ing A factors was .15 (95% CI: .05 to .25) and an overlap of approx-
mately 83%. For cerebral graymatter volume (in particular, cortical
rontal and occipital) the influence of common environmental fac-
ors (C) could not be dropped from the model. A near-significant
henotypic correlation was found between gray matter and Sz
rph.08, 95% CI:.16 to .00).
Discussion
In the largest twin study to date of Sz and BVs (n 684 individ-
uals) we examined the relative contributions of genetic and envi-
ronmental influences on the association of BVs and Sz. In an inter-
national multicenter collaboration we pooled data from four
research centers, creating a uniquely powered twin cohort. We
found a small but significant association between Sz and a smaller
Figure 2. Correlation between cerebral volume of Twin 1 with Twin 2 for (A
of illness.
Table 3. Standardized Estimates of the Full Bivariate ACE Genetic Models f
h2 BV c
2
BV e
2
BV
Cerebrum .76 (.57/.82)a .00 (0/.18) .24 (.18/.32)a
Cerebral Gray .34 (.00/.63) .23 (0/.53) .43 (.34/.55)a
Cerebral White .63 (.32/.79)a .10 (0/.38) .27 (.21/.36)a
Lateral Ventricles .71 (.31/.80)a .02 (0/.39) .27 (.20/.37)a
rd Ventricle .64 (.29/.81)a .11 (0/.40) .25 (.18/.33)a
Frontal Cortical Gray .43 (.00/.67) .13 (0/.53) .44 (.33/.57)a
Temporal Cortical Gray .52 (.13/.65)a .02 (0/.36) .45 (.34/.59)a
Parietal Cortical Gray .67 (.29/.76)a 0 (0/.34) .33 (.24/.44)a
ccipital Cortical Gray .21 (.00/.61) .43 (.06/.64)a .36 (.27/.48)a
Values given are n (95% confidence interval). h2, c2, e2 standardized a
components; rg, rc, regenetic, shared, andunshared environmental correla
2.11, e2.08 and prevalence of 1%.Abbreviations as in Tables 1 and 2.
aConfidence intervals not including zero indicate significance.erebral volume, of which 77% can be explained by genetic factors
hat influence both the lower cerebral volume and (the risk for
eveloping) Sz. Lower cerebral white matter volume as well as
arger third ventricular volume also showed a significant associa-
ion with the liability for Sz, which was largely explained by genetic
actors. These accounted for significant portions of the phenotypic
orrelations (94% and 83%, respectively), indicating that smaller
erebral (white) matter and larger third ventricle are related to the
enetic risk to develop Sz. Thus, our results suggest that the smaller
otal cerebral volume and particularly that of white matter and
arger third ventricle volume is linked to Sz, mainly through genetic
actors that are associated to the disorder. In contrast, a significant
nvironmental correlation for cerebral gray matter (.36; 95% CI:
.55 to.15) and cortical frontal graymatter (.54; 95%CI:.74 to
.29) was found, without a significant phenotypic association be-
ween smaller cerebral or cortical frontal and occipital gray matter
olume and liability to Sz. Interestingly, there are contrasting con-
ributions (although not significant) of genetic and common envi-
onmental factors. In otherwords, a negative associationwas found
etween genetic factors and lower volume, whereas common en-
ironmental factors showed a positive association with larger gray
atter volume. This is in line with a recent study in MZ twins
oncordant and discordant for Sz showing a heterogeneous pat-
ern of prefrontal volume reduction in twins with Sz. Medial and
onozygotic (n 196) and (B) all dizygotic (n 131) twin pairs, irrespective
nd Each MRI BV
rg rc re rph
(.42/.02)a .99 (1/1) .37 (.57/.14)a .22 (.30/.14)a
(.1/.16) 1 (1/1) .36 (.55/.15)a .08 (.16/.00)
(.41/.13) .97 (1/1) .09 (.31/.15) .17 (.25/.09)a
(.27/.47) .99 (1/1) .41 (.13/.65)a .10 (0/.19)
(.21/.43) 1 (1/1) .23 (.07/.49) .19 (.09/.28)a
(1/1) .51 (1/1) .54 (.74/.29)a .03 (.13/.06)
(.56/.35) .99 (1/1) .34 (.58/.07)a .04 (.14/.06)
(.27/.46) .57 (1/1) .26 (.50/.02) .03 (.07/.13)
(1/.07) 1 (1/1)a .08 (.33/.18) .01 (.09/.11)
ve genetic, shared environmental, and nonshared environmental variance
ph total phenotypic correlation. Fixed (genetic)model for Sz used:h
2.81,or Sz a
.21
.33
.08
.11
.06
.01
.04
.08
.48
dditi
tion; rwww.sobp.org/journal
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920 BIOL PSYCHIATRY 2012;71:915–921 N.E.M. van Haren et al.orbital frontal cortex showed significant volumetric reductions in
twins with Sz only if they were concordant but not discordant for
the disorder, relative to control subjects. In contrast, inferior frontal
cortex showed no statistically significant differences across groups,
whereas superior frontal cortex was reduced in Sz patients, regard-
less of their concordance status (41).
That impaired brain development is important in the pathogen-
esis of Sz is not new (42,43). Evidence fromboth genetic and epide-
miological studies that aberrant neurodevelopment is crucial in the
risk for Sz ismounting. Association studies have identified common
risk variants that are associatedwith Sz (e.g., neuregulin, dysbindin,
Disrupted in Schizophrenia 1 [DISC1]). In addition, small structural
changes (copy number variants) in the genome seem causative of
Sz. Interestingly, these genes as well as the copy number variants
seem to influence neurodevelopment, cell signaling, and synaptic
functions (44). Moreover, Fatemi and Folom (45) imply that Neu-
regulin-I and DISC1 not only play a key role in brain development
but are likely to be functionally convergent.
Epidemiological data show that deficits and delays in cognitive
development (46–48), emotional problems, interpersonal difficul-
ties, and impairments in neuromotor and receptive language (48)
are present during childhood and adolescence in individuals who
will later go on to develop Sz. Crucially, the risk for Sz is increased in
thosewith a lower IQ score, in particular in thepresenceof impaired
nonverbal reasoning (49). Furthermore, recent work has shown that
there are significant commongenetic influences acting on the covari-
ancebetween IQ, schizotypy, abnormal social functioning, and schizo-
phrenia (50). This suggests that the same genetic factors that impair
intelligence, increase schizotypy, impede social development, andde-
crease BV in childhood also determine the liability to Sz (39,50).
Although we found a significant association between Sz and
smaller cerebral volume, the correlation is relatively low, rph.22.
his subtle effectmightnotbe surprising, because itwasnotexpected
hat the risk for Sz explains a large part of the variance in cerebral
olume. A correlation of .22 indicates that susceptibility for Sz ex-
lains 4.8%of the variance,which is small but by nomeans negligible.
his is even lower for white matter volume (.17). Importantly, our
esults show that this effect in cerebrum and cerebral white matter is
argely (77%and94%, respectively)explainedbysharedgenetic rather
han environmental or disease-related factors. The genetic contribu-
ion to association between white matter volume and Sz liability has
een suggested previously with a classic repeated measures General
inear Model analyses in the Utrecht discordant twin sample (51). Of
ote, these data are also part of the current pooled sample.
Our findings must be viewed in light of several methodological
imitations. First, this pooled twin sample is not a population-based
ample of twins with Sz and healthy control twins from the United
ingdom, The Netherlands, and Germany, except for the twin sam-
le from Helsinki. Second, this study found no significant shared
nvironment contribution to the variation in BVs, which rules it out
s a possible source of overlap with the disorder. However, by
onstraining the BV familial environmental paths to zero in the AE
odel for some volumes, its effects (even if very small) will auto-
atically be apportioned to the genetic component, therefore in-
ating the genetic correlation between BV and disorder. Third, we
annot distinguish how much each site contributes to the ex-
lained variation in BVdue toAor E. Fourth, in the present studywe
annot account for biological gene environment interaction ef-
ects, because in the classical twin model the effects of interaction
nd correlation between latent A, C, and E factors is assumed to be
ero. Twin data on their own cannot resolve these issues. There are
rather complex) designs that enable ways of testing these effects
52), but that is beyond the scope of most twin studies.
www.sobp.org/journalFinally, the findings of our study are limited to global BV mea-
ures. The advantage of global BVs is their robustness and stability
n measurements, as is indicated by the relatively high ICCs we
ound across sites. In contrast, the reliability of voxel-based and
ortical thickness measurements seem to differ between brain ar-
as (53).We canmakenoanatomically specific inferences about the
ocation of the focal gray and white matter deficits and how they
ight be differently related to the genetic and environmental risk
o develop Sz. Future studies should deploy more focally sensitive
pproaches to brain anatomy with voxel-based morphometry or
ortical thickness measurements. In addition, associations with
ther candidate endophenotypicmarkers such as intellectual func-
ioning (IQ) need to be investigated.
In conclusion, we found that genetic factors largely explain the
odest but significant association between Sz and total cerebral
nd white matter volume decrease and increase in third ventricle
olume. These findings indicate that some of the genes that in-
rease the risk to develop Sz are likely to be involved in crucial
eurodevelopmental processes in the brain. Thus, evidence from
enetic, epidemiological, and—as indicated by the current re-
ults—neuroimaging studies seem to converge on the fact that the
isk to develop Sz is the consequence of geneticallymediated aber-
ant neurodevelopment.
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